APOM and Insulin resistance: Moreover, the present study may open a new sight into the pathophysiological procedure of the apoM and apoM overexpression for a potential role on improving lipoprotein metabolism in vivo, which could be considered as a future therapeutic target against insulin resistance and type-2 diabetes.